Ceapro Inc V.CZO

Chemicals Specialty Chemicals

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.

TSXV:CZO - Post by User

Ceapro Inc > CZO's PGX-OBG and PGX-YBG

<< Previous

Bullboard Posts

Next >>

Comment by stockfyon Jan 23, 2021 5:13am

111 Views

Post# 32367160

RE:CZO's PGX-OBG and PGX-YBG

Facts.

stockfy wrote:

Let's sum it up:

CZO's PGX oat beta glucan: This is in a human clinical trial under the influencial Dr. Jean Claude Tardif at the Montreal Heart Institute. Patients are being enrolled and randomized and results are expected this year. PGX OBG is for the cholesterol reducing pill and a functional drink, facts below:

https://www.ceapro.com/nutraceuticals/oat-beta-glucan

CZO's PGX yeast beta glucan: The Canadian Government has provided funding towards mass production and a clinical trial. CZO collaborates with McMaster, a university that ranks in the top 1% of universities in the world.This PGX-YBG will be tested as a potential inhalable therapeutic for COVID-19 and other fibrotic end-point diseases of the lung, facts below:

https://www.globenewswire.com/news-release/2020/11/27/2135353/0/en/Ceapro-Inc-Reports-2020-Third-Quarter-and-Nine-Month-Financial-Results-and-Operational-Highlights.html

In the meantime, CZO is profitable, debt-free with a significant amount of cash and trades just about 8.5 times its 2020 EBITDA.